Where is this new round of mergers and acquisitions coming from? Is the pharmaceutical industry in danger of consuming itself in its endless quest for profit?
Mike Cola and Sylvie Gregoire of Shire Pharmaceuticals explain why being different is increasingly important in the dark days of economic recession.
The U.S. healthcare industry continues to face an unprecedented period of turbulence and uncertainty that provides significant challenges to each of its public health stakeholder groups. By Verix
IONICS Mass Spectrometry Group Inc. from Bolton, Canada is now introducing, recently announced new product, a new triple quadrupole mass spectrometer and data acquisition and processing system; the IONICS 3Q Molecular AnalyzerTM and MolAnaTM, respectively.
How a fresh perspective and new visualization tools can improve clinical trial management. By General Dynamics